Skip to main content
Top
Published in: Supportive Care in Cancer 12/2016

01-12-2016 | Original Article

Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement

Authors: Gabriel Liberale, Michel El Houkayem, Claire Viste, Fikri Bouazza, Michel Moreau, Issam El Nakadi, Isabelle Veys

Published in: Supportive Care in Cancer | Issue 12/2016

Login to get access

Abstract

Purpose

Totally implantable vascular access devices (TIVADs) are widely used to administer chemotherapy to cancer patients. While great progress has been made with respect to breast surgical reconstruction to take into account both aesthetics and patients’ perceptions of body integrity, these aspects have not been considered with regard to the impact of TIVAD. In order to address this practice gap, we have adapted our TIVAD implantation technique to improve cosmetic results. The aim of this study was to assess breast cancer patients’ comfort level and aesthetic satisfaction with regard to TIVAD insertion.

Methods

Patients with breast cancer admitted for chemotherapy at an outpatient clinic completed a previously validated survey evaluating three main domains: symptoms (pain, discomfort) related to the TIVAD itself in daily activity, information received before and during the surgical procedure, and cosmetic aspects regarding the port insertion site (scar, port, and catheter location).

Results

Between September 2010 and June 2011, 232 patients were evaluated. Cosmetic satisfaction with scar location was high (93.3 %). Information given to patients before and during the procedure had a major impact on both symptom perception in daily activity and on cosmetic satisfaction.

Conclusions

Obtaining a more aesthetic scar by placing the TIVAD in the deltopectoral groove contributed to a high rate of cosmetic satisfaction. Furthermore, the relevance of information given to patients before and/or during surgery had a major impact on symptom perception. Therefore, we suggest including a pre-operative information session in the care pathway.
Literature
1.
go back to reference Zaghal A, Khalife M, Mukherji D, El Majzoub N, Shamseddine A, Hoballah J, Marangoni G, Faraj W (2012) Update on totally implantable venous access devices. Surg Oncol 21:207–215CrossRefPubMed Zaghal A, Khalife M, Mukherji D, El Majzoub N, Shamseddine A, Hoballah J, Marangoni G, Faraj W (2012) Update on totally implantable venous access devices. Surg Oncol 21:207–215CrossRefPubMed
2.
go back to reference Tagliari AP, Staub FL, Guimarães JR, Migliavacca A, Mossmann Dda F (2015) Evaluation of three different techniques for insertion of totally implantable venous access device: a randomized clinical trial. J Surg Oncol 112:56–59CrossRefPubMed Tagliari AP, Staub FL, Guimarães JR, Migliavacca A, Mossmann Dda F (2015) Evaluation of three different techniques for insertion of totally implantable venous access device: a randomized clinical trial. J Surg Oncol 112:56–59CrossRefPubMed
3.
go back to reference Orci LA, Meier RPH, Morel P, Staszewicz W, Toso C (2014) Systematic review and meta-analysis of percutaneous subclavian vein puncture versus surgical venous cutdown for the insertion of a totally implantable venous access device. Br J Surg 101:8–16CrossRefPubMed Orci LA, Meier RPH, Morel P, Staszewicz W, Toso C (2014) Systematic review and meta-analysis of percutaneous subclavian vein puncture versus surgical venous cutdown for the insertion of a totally implantable venous access device. Br J Surg 101:8–16CrossRefPubMed
4.
go back to reference Borst C, de Kruif A, van Dam F, de Graaf P (1992) Totally implantable venous access ports—the patients’ point of view. A quality control study. Cancer Nurs 15:378–381CrossRefPubMed Borst C, de Kruif A, van Dam F, de Graaf P (1992) Totally implantable venous access ports—the patients’ point of view. A quality control study. Cancer Nurs 15:378–381CrossRefPubMed
5.
go back to reference Kim MK, Kim T, Moon HG, Jin US, Kim K, Kim J, Lee JW, Kim J, Lee E, Yoo TK, Noh DY, Minn KW, Han W (2015) Effect of cosmetic outcome on quality of life after breast cancer surgery. Eur J Surg Oncol 41:426–432CrossRefPubMed Kim MK, Kim T, Moon HG, Jin US, Kim K, Kim J, Lee JW, Kim J, Lee E, Yoo TK, Noh DY, Minn KW, Han W (2015) Effect of cosmetic outcome on quality of life after breast cancer surgery. Eur J Surg Oncol 41:426–432CrossRefPubMed
6.
go back to reference Kreis H, Loehberg CR, Lux MP, Ackermann S, Lang W, Beckmann MW, Fasching PA (2007) Patients’ attitudes to totally implantable venous access port systems for gynaecological or breast malignancies. Eur J Surg Oncol 33:39–43CrossRefPubMed Kreis H, Loehberg CR, Lux MP, Ackermann S, Lang W, Beckmann MW, Fasching PA (2007) Patients’ attitudes to totally implantable venous access port systems for gynaecological or breast malignancies. Eur J Surg Oncol 33:39–43CrossRefPubMed
7.
go back to reference Biffi R, Orsi F, Pozzi S, Maldifassi A, Radice D, Rotmentsz N, Zampino MG, Fazio N, Peruzzotti G, Didier F (2011) No impact of central venous insertion site on oncology patients’ quality of life and psychological distress. A randomized three-arm trial. Support Care Cancer 19:1573–1580CrossRefPubMed Biffi R, Orsi F, Pozzi S, Maldifassi A, Radice D, Rotmentsz N, Zampino MG, Fazio N, Peruzzotti G, Didier F (2011) No impact of central venous insertion site on oncology patients’ quality of life and psychological distress. A randomized three-arm trial. Support Care Cancer 19:1573–1580CrossRefPubMed
8.
go back to reference Singh KR, Agarwal G, Nanda G, Chand G, Mishra A, Agarwal A, Verma AK, Mishra SK, Goyal P (2014) Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage. World J Surg 38:1084–1092CrossRefPubMed Singh KR, Agarwal G, Nanda G, Chand G, Mishra A, Agarwal A, Verma AK, Mishra SK, Goyal P (2014) Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage. World J Surg 38:1084–1092CrossRefPubMed
Metadata
Title
Evaluation of the perceptions and cosmetic satisfaction of breast cancer patients undergoing totally implantable vascular access device (TIVAD) placement
Authors
Gabriel Liberale
Michel El Houkayem
Claire Viste
Fikri Bouazza
Michel Moreau
Issam El Nakadi
Isabelle Veys
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3368-y

Other articles of this Issue 12/2016

Supportive Care in Cancer 12/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine